Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1984 1
1986 1
1989 1
1990 2
1991 2
1992 2
1993 2
1994 1
1995 2
1996 3
1997 2
1998 2
1999 3
2001 4
2002 3
2003 5
2004 4
2005 6
2006 4
2007 6
2008 8
2009 10
2010 11
2011 6
2012 7
2013 14
2014 17
2015 18
2016 27
2017 18
2018 18
2019 19
2020 14
2021 20
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Results by year
Filters applied: . Clear all
Page 1
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care.
Bedke J, Albiges L, Capitanio U, Giles RH, Hora M, Lam TB, Ljungberg B, Marconi L, Klatte T, Volpe A, Abu-Ghanem Y, Dabestani S, Pello SF, Hofmann F, Kuusk T, Tahbaz R, Powles T, Bex A. Bedke J, et al. Among authors: hora m. Eur Urol. 2021 Oct;80(4):393-397. doi: 10.1016/j.eururo.2021.04.042. Epub 2021 May 29. Eur Urol. 2021. PMID: 34074559
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB, Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. Ljungberg B, et al. Among authors: hora m. Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26. Eur Urol. 2022. PMID: 35346519 Free article.
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Tahbaz R, Volpe A, Bex A. Ljungberg B, et al. Among authors: hora m. Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23. Eur Urol. 2019. PMID: 30803729
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma.
Bedke J, Albiges L, Capitanio U, Giles RH, Hora M, Lam TB, Ljungberg B, Marconi L, Klatte T, Volpe A, Abu-Ghanem Y, Dabestani S, Fernández-Pello S, Hofmann F, Kuusk T, Tahbaz R, Powles T, Bex A. Bedke J, et al. Among authors: hora m. Eur Urol. 2021 Mar;79(3):339-342. doi: 10.1016/j.eururo.2020.12.005. Epub 2020 Dec 24. Eur Urol. 2021. PMID: 33357997
Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne.
Nison L, Colin P, Remzi M, Shariat S, Klatte T, Yakoubi R, Bozzini G, Capitanio U, Babjuk M, Merseburger A, Cha E, Fritsche H, Novara G, Montorsi F, Hora M, Roupret M. Nison L, et al. Among authors: hora m. Prog Urol. 2015 Nov;25(13):807. doi: 10.1016/j.purol.2015.08.182. Prog Urol. 2015. PMID: 26544377 French. No abstract available.
EAU guidelines on renal cell carcinoma: 2014 update.
Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A. Ljungberg B, et al. Among authors: hora m. Eur Urol. 2015 May;67(5):913-24. doi: 10.1016/j.eururo.2015.01.005. Epub 2015 Jan 21. Eur Urol. 2015. PMID: 25616710 Review.
[Priapism].
Hora M, Ouda Z. Hora M, et al. Cas Lek Cesk. 1999 Mar 1;138(5):131-5. Cas Lek Cesk. 1999. PMID: 10376395 Review. Czech.
[The physiology of erection].
Hora M, Vozeh F. Hora M, et al. Cas Lek Cesk. 1997 Jun 12;136(12):363-6. Cas Lek Cesk. 1997. PMID: 9333507 Review. Czech.
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.
Fernández-Pello S, Hofmann F, Tahbaz R, Marconi L, Lam TB, Albiges L, Bensalah K, Canfield SE, Dabestani S, Giles RH, Hora M, Kuczyk MA, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A. Fernández-Pello S, et al. Among authors: hora m. Eur Urol. 2017 Mar;71(3):426-436. doi: 10.1016/j.eururo.2016.11.020. Epub 2016 Dec 8. Eur Urol. 2017. PMID: 27939075 Review.
Physical basis of amyloid fibril polymorphism.
Close W, Neumann M, Schmidt A, Hora M, Annamalai K, Schmidt M, Reif B, Schmidt V, Grigorieff N, Fändrich M. Close W, et al. Among authors: hora m. Nat Commun. 2018 Feb 16;9(1):699. doi: 10.1038/s41467-018-03164-5. Nat Commun. 2018. PMID: 29453354 Free PMC article.
238 results